Saint Alphonsus Med. Ctr.–Nampa, Inc. v. St. Luke’s Health Sys., Ltd. (Summary)
MERGER
Saint Alphonsus Med. Ctr. – Nampa, Inc. v. St. Luke’s Health Sys., Ltd., No. 14-35173 (9th Cir. Feb. 10, 2015)
The U.S. Court of Appeals for the Ninth Circuit affirmed a district court’s ruling that a merger of two health care providers had violated §7 of the Clayton Act. Although the district court agreed with the hospitals’ claim that this merger could improve patient outcomes, it determined that the post-merger entity would have such a huge market share that it would create a “substantial risk of anticompetitive price increases” in the relevant market.
Under the Clayton Act, the party challenging the merger must first put forth a prima facie case that the merger is anticompetitive. The parties who are defending the merger then take on the burden of reing this claim and showing that the merger does not violate the Clayton Act. The Ninth Circuit noted that it is often very difficult for courts to assess what kind of impact a merger might have on competition at some later date. It emphasized the point with a quote commonly attributed to Yogi Berra: “It’s tough to make predictions, especially about the future.”
All of the parties in the case agreed that the relevant product market under review was adult primary care providers (“PCPs”), but they clashed over how to set the appropriate geographic boundaries. One key dispute centered on whether this merger would result in a small but significant price increase in the relevant market. St. Luke’s, a hospital involved in the merger, had argued that the district court erred by focusing its price analysis on the city of Nampa, Idaho. The hospital pointed to evidence that one-third of Nampa residents instead travel to Boise to see a primary care provider, and suggested that more residents would travel to Boise for better prices.
The Ninth Circuit disagreed. It noted that Nampa consumers often choose physicians on factors other than price alone, and reasoned that insurers would generally need local PCPs in order to market their health care plans. Consequently, it concluded that this merger presented a genuine risk of price increases in the market. Although it disagreed with the way the district court had handled its analysis of hospital-based ancillary services, the Ninth Circuit concluded that otherwise the district court had made an appropriate decision that was “amply supported by the record.”
Lastly, the court addressed counter-arguments brought up by St. Luke’s, emphasizing how the merger could benefit patients. The Ninth Circuit agreed that improving patient care was a “laudable goal,” but reiterated that “the Clayton Act does not excuse mergers that lessen competition or create monopolies simply because the merged entity can improve its operations.” It affirmed the district court’s decision to order divestiture.